Success Metrics

Clinical Success Rate
85.7%

Based on 6 completed trials

Completion Rate
86%(6/7)
Active Trials
1(8%)
Results Posted
17%(1 trials)
Terminated
1(8%)

Phase Distribution

Ph not_applicable
9
75%
Ph phase_3
1
8%
Ph phase_4
1
8%

Phase Distribution

0

Early Stage

0

Mid Stage

2

Late Stage

Phase Distribution11 total trials
Phase 3Large-scale testing
1(9.1%)
Phase 4Post-market surveillance
1(9.1%)
N/ANon-phased studies
9(81.8%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

6 of 8 finished

Non-Completion Rate

25.0%

2 ended early

Currently Active

1

trials recruiting

Total Trials

12

all time

Status Distribution
Active(1)
Completed(6)
Terminated(2)
Other(3)

Detailed Status

Completed6
unknown3
Withdrawn1
Terminated1
Recruiting1

Development Timeline

Analytics

Development Status

Total Trials
12
Active
1
Success Rate
85.7%
Most Advanced
Phase 4

Trials by Phase

Phase 31 (9.1%)
Phase 41 (9.1%)
N/A9 (81.8%)

Trials by Status

withdrawn18%
terminated18%
completed650%
unknown325%
recruiting18%

Recent Activity

Clinical Trials (12)

Drug Details

Intervention Type
PROCEDURE
Total Trials
12